Latest Advisory

Please be informed that the Unified Licensing Seminar (ULS-X) on 25 October 2018 and QPIRA CFRR (QCFRR-MIN) on 25-26 October 2018 shall be held in APPLE TREE RESORT AND HOTEL.

  • VENUE     : APPLE TREE RESORT AND HOTEL
  • ADDRESS : Zone-2, Taboc, Opol Misamis Oriental

All course registrants who received Course Assessment Slip but have not received the Course Confirmation Slip are advised to come in the seminar with the following documents:

  • Course Assessment Slip
  • Proof of Payment
  • Original Copy of Notarized Affidavit of Undertaking ( For QPIRA Participants only)

Rest assured that the stakeholders with the above documents will be accepted to the seminar. For inquiries and other concerns, please call the FDA Academy at telephone number (02) 877 0259.

 

The Food and Drug Administration(FDA) is pleased to announce the transfer of the Food and Drug Action Center (FDAC) Alabang from the 4th Floor of Civic Prime Building to the 3rd Level of Starmall Alabang Effective 29 October 2018 (Monday). Operations on the said date will start at 10:00am to give away to the traditional office blessing and formal turnover. Normal business hours, 8am to-5pm, will be followed on succeeding working days. For your information, reference and guidance.

 The Food and Drug Administration (FDA) recently reported major gains in its bid to reduce the backlog in pending applications filed before the agency.

FDA Director-General Nela Charade Puno said the agency has already reduced by some 3,500 the estimated backlog of about 80,000 applications left pending in the past, including those unattended to under previous administrations.

She said the FDA is set to reduce the number by 1,400 following the verification and posting of these applications in the agency’s E-Portal and subsequent action by the various FDA Centers.

Puno explained that the gains were made possible by a dedicated technical team under the direct supervision of the FDA head which undertook the evaluation and disposition of the pending applications for licenses to operate and certificates of product registration/notification.

Puno said the FDA expects to significantly clear the backlog by the first quarter of next year in line with the agency’s “Project: Zero backlog”.

Puno earlier announced that that agency has taken drastic moves to address the backlog in the processing of various applications from the agency in a bid to make way for more efficient systems and to get rid of so-called “nuisance applications”.

She also warned that the FDA will set stricter requirements for future applications “to weed out the nuisances and to enable the FDA to attend to the needs of serious and legitimate applicants”.

Puno had also earlier pointed out that the current backlog “appears to have been at the FDA for close to a decade and have been left unattended”. A large percentage of the backlog is the result of the inability of applicants to submit product registration requirements, she noted.

Please be informed that the Unified Licensing Seminar scheduled on 18 October 2018 in Cebu City shall be in WATERFRONT CEBU CITY HOTEL AND CASINO.

  • VENUE         : WATERFRONT CEBU CITY HOTEL AND CASINO
  • ADDRESS    : Salinas Drive, Cebu City, Cebu

All course registrants who received Course Assessment Slip for the Unified Licensing Seminar but have not received the Course Confirmation Slip are advised to come in the seminar with the following documents:

  • Course assessment slip
  • Proof of payment

Rest assured that the stakeholders with the above documents will be accepted to the seminar. For inquiries and other concerns, please call the FDA Academy at telephone number (02) 877 0259.

This is to inform you that the Unified Licensing Seminar for Region VI Stakeholders (ULS-VI) on 16 October 2018 to be held in Bacolod City shall be postponed due to very low number of participants. Registered participants of this seminar shall be included in the new schedule of ULS-VI. Please visit the FDA website and Facebook page for updates on this seminar.

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter